Replacement of hospital clinic appointments with telehealth appointments delivered directly to the home for people with cystic fibrosis (CF)

Not Applicable

Withdrawn

• Conditions: Cystic Fibrosis; Respiratory - Other respiratory disorders / diseases; Human Genetics and Inherited Disorders - Cystic fibrosis

• Registration Number: ACTRN12620000311954
• Lead Sponsor: Macquarie University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-06
• Last Update Posted: 21 July 2021

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Adults and children with diagnosis of CF confirmed with sweat test, abnormal nasal potential difference and/or genetic testing
-Clinical care managed by a CF specialist multidisciplinary team at one of the participating hospitals
-Age > 6 months
-Participants with resting SpO2 < 95% on room air will require a home SpO2 monitor for inclusion in the trial (as SpO2 measurement would form part of usual clinical care in this group)
-Clinically stable without antibiotic treatment for a pulmonary exacerbation in the two weeks prior to the screening visit

Exclusion Criteria

-FEV1 <30%
-Unable to receive all prescribed medications without physically attending CF centre
-Lack of internet availability in the home or other reason for inability to connect to NSW Health teleconferencing platform
-Technological limitation to use of portable spirometer (e.g. incompatible device)
-Inability to speak and read the English language well enough to complete questionnaires

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite score on the Treatment Burden Questionnaire (TBQ)[At randomisation<br>At twelve months after randomisation ]